Viking Thera (VKTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
25.65 -0.48 (-1.84%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 25.50 -0.15 (-0.58%) 19:50 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Operating Expenses | 150,921 | 100,827 | 70,355 | 55,682 | 42,662 |
Operating Income | -150,921 | -100,827 | -70,355 | -55,682 | -42,662 |
Other Income | 40,958 | 14,932 | 1,488 | 692 | 3,167 |
Pre-tax Income | -109,963 | -85,895 | -68,867 | -54,990 | -39,495 |
Net Income Continuous | -109,963 | -85,895 | -68,867 | -54,990 | -39,495 |
Net Income | $-109,963 | $-85,895 | $-68,867 | $-54,990 | $-39,495 |
EPS Basic Total Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
EPS Basic Continuous Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
EPS Diluted Total Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
EPS Diluted Continuous Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
EPS Diluted Before Non-Recurring Items | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
EBITDA(a) | $-167,748 | $-108,649 | $-68,788 | $-51,462 | $-38,471 |